Megalobastic anemia, infantile leukemia, and immunodeficiency caused by a novel homozygous mutation in the DHFR gene

Taco W. Kuijpers*, Andrica C.H. de Vries, NIHR BioResource Study Group, Ester M. van Leeuwen, A. A.M. Ermens, Saskia de Pont, Desirée E.C. Smith, Mirjam M.C. Wamelink, Arjen R. Mensenkamp, Marcel R. Nelen, Hana Lango Allen, Steven T. Pals, Berna H.B. Beverloo, Hidde H. Huidekoper, Anja Wagner

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
34 Downloads (Pure)


Dihydrofolate reductase (DHFR) is a critical enzyme in folate metabolism that reduces folic acid to dihydrofolic and tetrahydrofolic acid and provides an important target for antineoplastic, antimicrobial, and anti-inflammatory drugs. Defective DHFR activity leads to megaloblastic anemia syndrome combined with severe cerebral folate deficiency, and cerebral tetrahydrobiopterin deficiency due to a germ line missense mutation in DHFR has been reported.1,2 Folate represents a large family of water-soluble vitamins that play an important role in DNA synthesis, repair, and transmethylation pathways.3 Folate is also a substrate for purine and thymidine synthesis and a methyl donor for homocysteine to methionine conversion, with low folate status being reflected by elevated plasma homocysteine concentrations.4 Cerebral tetrahydrobiopterin is required for the formation of dopamine, serotonin, and norepinephrine and the hydroxylation of aromatic amino acids as a link to neurodevelopmental symptoms.

Original languageEnglish
Pages (from-to)5829-5834
Number of pages6
JournalBlood advances
Issue number22
Publication statusPublished - 22 Nov 2022

Bibliographical note

Funding Information:
This study was supported by The National Institute for Health Research England (grant number RG65966) and the Center of Immunodeficiencies Amsterdam (CIDA-2015).

Publisher Copyright:
© 2022 by The American Society of Hematology.


Dive into the research topics of 'Megalobastic anemia, infantile leukemia, and immunodeficiency caused by a novel homozygous mutation in the DHFR gene'. Together they form a unique fingerprint.

Cite this